Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, American Century International Growth Fund. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD+1.87%
Annualized+6.88%
Positioning StanceConstructive
Market CapLarge Cap
GeographyEurope, Asia, Global
Digest Analysis
Quick Take
"American Century's International Growth Fund returned 1.87% in Q1 2025, underperforming the MSCI EAFE benchmark amid U.S. policy uncertainty. The fund targets undervalued large-cap companies in developed markets outside the U.S., focusing on Europe recovery opportunities, technology digitalization trends, pharmaceutical innovation in obesity and cancer treatments, and ingredients makers benefiting from volume growth acceleration."
Executive Summary
American Century's International Growth Fund targets long-term capital growth through large companies in developed markets outside the U.S. The fund returned 1.87% in Q1 2025, underperforming the MSCI EAFE benchmark's 6.86% return. Major policy shifts in the U.S. are creating tectonic changes in global markets and geopolitical order, with tariff uncertainty causing business leaders to delay decisions. The portfolio focuses on companies that are strong and improving but undervalued by markets. Key themes include Europe-focused companies positioned for near-term improvement as economic activity moderates and government spending increases, particularly in Germany's military and infrastructure sectors. Technology holdings benefit from digital transformation acceleration, cloud computing growth, and AI integration across sectors. Healthcare positions target pharmaceutical innovation in obesity, cancer, and skin conditions. The fund maintains exposure to ingredients makers positioned to benefit from volume growth as inflation pressures ease. Notable trades included initiating positions in Sony Group and Siemens while exiting Techtronic Industries and Tokio Marine Holdings to reduce cyclical exposure and capture realized gains.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
75%
Market Conviction
The manager demonstrates high conviction through specific thematic positioning, detailed company analysis, and clear rationale for trades. They articulate definitive views on European recovery, AI integration benefits, and pharmaceutical innovation opportunities while making decisive portfolio changes.
38%
Growth Outlook
The manager expresses concern about tectonic shifts from U.S. policy changes, tariff confusion weighing on business leaders, and potential stagflationary environment in the U.S. However, they note modest economic improvement in Europe and supportive government spending, creating a mixed but slightly negative overall market outlook.
57%
Risk Appetite
The portfolio shows selective risk-taking with new positions in Sony Group and Siemens while reducing cyclical exposure by exiting Techtronic Industries. The manager maintains exposure to growth themes like AI and pharmaceutical innovation, indicating moderate risk appetite with tactical adjustments.
20%
Capital Deployment
The fund shows moderate net deployment activity with new positions in Sony Group and Siemens while exiting Techtronic Industries and Tokio Marine Holdings. The activity suggests selective capital reallocation rather than aggressive deployment or significant de-risking.
65%
Forward Guidance
The manager expresses confidence in their investment themes and positioning, stating they continue to invest in companies they believe are strong and improving. They identify multiple growth catalysts including European recovery, digital transformation, and pharmaceutical innovation, showing constructive forward-looking bias.
55%
Language Signal
Language contains balanced mix of risk awareness (tariff confusion, stagflation concerns) and opportunity identification (near-term improvement, growth inflection, tremendous investment opportunity). The tone is professional and measured with slight positive bias toward identified themes.
65%
Perceived Risk
The manager identifies significant macro risks including U.S. policy uncertainty, tariff confusion causing business decision delays, and potential stagflationary environment. They also note tectonic shifts in global markets and geopolitical order, indicating elevated risk perception.
70%
Opportunity Density
The manager identifies multiple investment themes and opportunities across regions and sectors, including European recovery, AI integration, pharmaceutical innovation, and ingredients makers. They express confidence in finding companies that are strong and improving but undervalued by markets.
80%
Time Horizon
The fund's stated objective is long-term capital growth, and the manager discusses structural themes like digital transformation, AI integration, and pharmaceutical innovation that suggest patient capital deployment with multi-year investment horizons.